JAKARTA, KOMPAS.com – Indonesia’s state-owned pharmaceutical company Bio Farma will produce more Covid-19 vaccine after receiving the bulk vaccine from China’s Sinovac shortly.
“We have made an agreement with Sinovac who will send 140 million doses of Covid-19 bulk vaccine based on the agreed timeline,” said Bio Farma president director Honesti Basyir in a press conference on Tuesday, February 16.
This announcement was made following the production of 13 million doses of ready-to-use vaccine by Bio Farma. Previously, the company received 15 million doses of bulk vaccine from Sinovac on January 12.
"This achievement will certainly be an encouragement for us to maintain the stability of the supply of the covid-19 vaccine," said Honesti.
He further added with the issuance of the Emergency Use Authorization (EUA) for the Covid-19 vaccine, Bio Farma would distribute 7.5 million doses of ready-to-use vaccine for the second phase of the mass vaccination program.
“The 7.5 million doses will be provided for non-healthcare workers,” he said.
(Writer: Haryanti Puspa Sari | Editor: Diamanty Meiliana)